Comparative 12‐week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real‐world multicenter retrospective study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-08, Vol.34 (8), p.e416-e418
Hauptverfasser:	Georgakopoulos, J.R., Lam, K., Sandhu, V.K., Ighani, A., Phung, M., Piguet, V., Yeung, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized Biological Factors Dermatologic Agents - adverse effects Dermatology Humans Life Sciences & Biomedicine Psoriasis - drug therapy Retrospective Studies Science & Technology Severity of Illness Index Treatment Outcome Ustekinumab - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!